Summary of the Chronic Obstructive Pulmonary Disease Clinical Practice Guideline Revised in 2014 by the Korean Academy of Tuberculosis and Respiratory Disease

다국어 초록 (Multilingual Abstract)

Chronic obstructive pulmonary disease (COPD) results in high morbidity and mortality among patients both domestically and globally. The Korean clinical practice guideline for COPD was revised in 2014. It was drafted by the members of the Korean Academy of Tuberculosis and Respiratory Diseases, as well as participating members of the Health Insurance Review and Assessment Service, Korean Physicians’ Association, and Korea Respiration Trouble Association. This revised guideline covers a wide range of topics, including the epidemiology, diagnosis, assessment, monitoring, management, exacerbation, and comorbidities of COPD in Korea. We drafted a guideline on COPD management by performing systematic reviews on the topic of management with the help of a meta-analysis expert. We expect this guideline will be helpful medical doctors treating patients with respiratory conditions, other health care professionals, and government personnel in South Korea.

참고문헌 (Reference)

1 오인환, "한국인의 질병부담" 대한의사협회 54 (54): 646-652, 2011

2 진현정, "폐쇄성폐질환에서 우울증상의 빈도 및 위험 인자" 대한결핵및호흡기학회 65 (65): 191-197, 2008

3 최홍석, "주요우울장애의 선별 도구로서 한국판" 대한가정의학회 28 (28): 114-119, 2007

4 Lamprecht B, "Welte T, Nizankowska-Mogilnicka E, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study" 139 : 752-763, 2011

5 Vogelmeier C, "Tiotropium versus salmeterol for the prevention of exacerbations of COPD" 364 : 1093-1103, 2011

6 Chong J, "Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease" 9 : CD009157-, 2012

7 Statistics Korea, "The result of causes of death statistics in 2010" Statistics Korea 2011

8 임경희, "The Patient Health Questionnaire-9의 표준화 예비연구" 대한임상건강증진학회 9 (9): 275-281, 2009

9 Hurst JR, "Susceptibility to exacerbation in chronic obstructive pulmonary disease" 363 : 1128-1138, 2010

10 Kunik ME, "Surprisingly high prevalence of anxiety and depression in chronic breathing disorders" 127 : 1205-1211, 2005

11 Madsen H, "Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease: a population-based database study" 4 : 22-29, 2010

12 ZuWallack RL, "Salmeterol plus theophylline combination therapy in the treatment of COPD" 119 : 1661-1670, 2001

13 Calverley PM, "Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease" 356 : 775-789, 2007

14 Rabe KF, "Roflumilast: an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial" 366 : 563-571, 2005

15 Bateman ED, "Roflumilast with long-acting beta2-agonists for COPD: influence of exacerbation history" 38 : 553-560, 2011

16 Calverley PM, "Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials" 374 : 685-694, 2009

17 Fabbri LM, "Roflumilast in moderate-tosevere chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials" 374 : 695-703, 2009

18 Lee SD, "Roflumilast in Asian patients with COPD: a randomized placebo-controlled trial" 16 : 1249-1257, 2011

19 National Lung Screening Trial Research Team, "Reduced lung-cancer mortality with low-dose computed tomographic screening" 365 : 395-409, 2011

20 Burge PS, "Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial" 320 : 1297-1303, 2000

21 Sethi S, "Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial" 11 : 10-, 2010

22 Ni W, "Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis" 10 : e0121257-, 2015

23 Mathers CD, "Projections of global mortality and burden of disease from 2002 to 2030" 3 : e442-, 2006

24 Bousquet J, "Prioritised research agenda for prevention and control of chronic respiratory diseases" 36 : 995-1001, 2010

25 Hwang YI, "Prevalence of depression and its influence on health-related quality of life in COPD patients" 140 : 542A-, 2011

26 Yoo KH, "Prevalence of chronic obstructive pulmonary disease in Korea:the fourth Korean National Health and Nutrition Examination Survey, 2008" 16 : 659-665, 2011

27 류연주, "Prevalence of Depression and Anxiety in Outpatients with Chronic Airway Lung Disease" 대한내과학회 25 (25): 51-57, 2010

28 Ferguson GT, "Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study" 136 : 1456-1465, 2009

29 Sestini P, "Prescription bias and factors associated with improper use of inhalers" 19 : 127-136, 2006

30 Chong J, "Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease" 5 : CD002309-, 2011

31 Yamauchi Y, "Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan" 9 : 1337-1346, 2014

32 Stoller JK, "Oxygen therapy for patients with COPD: current evidence and the longterm oxygen treatment trial" 138 : 179-187, 2010

33 D’Urzo A, "Oneyear extension study of ACCORD COPD I: safety and efficacy of two doses of twice-daily aclidinium bromide in patients with COPD" 10 : 500-510, 2013

34 Kornmann O, "Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison" 37 : 273-279, 2011

35 Donohue JF, "Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium" 182 : 155-162, 2010

36 Beeh KM, "Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial" 7 : 503-513, 2012

37 D’Urzo A, "Once daily glycopyrronium for the treatment of COPD:pooled analysis of the GLOW1 and GLOW2 studies" 30 : 493-508, 2014

38 Sin DD, "Mortality in COPD: role of comorbidities" 28 : 1245-1257, 2006

39 Vestbo J, "Longterm effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial" 353 : 1819-1823, 1999

40 Pauwels RA, "Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease" 340 : 1948-1953, 1999

41 Gelb AF, "Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD" 107 : 1957-1965, 2013

42 Seemungal TA, "Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations" 178 : 1139-1147, 2008

43 Barr RG, "Inhaled tiotropium for stable chronic obstructive pulmonary disease" 2 : CD002876-, 2005

44 Kew KM, "Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease" 3 : CD010115-, 2014

45 Sethi S, "Infection in the pathogenesis and course of chronic obstructive pulmonary disease" 359 : 2355-2365, 2008

46 Kesten S, "Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients" 3 : 127-136, 2008

47 Martinez CH, "Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort" 15 : 62-, 2014

48 Anthonisen NR, "Hospitalizations and mortality in the Lung Health Study" 166 : 333-339, 2002

49 Kim C, "Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea" 18 : 737-743, 2014

50 Vestbo J, "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary" 187 : 347-365, 2013

51 Global Initiative for Chronic Obstructive Lung Disease (GOLD), "Global strategy for the diagnosis, management and prevention of COPD"

52 Jones PW, "Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study" 40 : 830-836, 2012

53 Szafranski W, "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease" 21 : 74-81, 2003

54 Beier J, "Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-tosevere chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study" 10 : 511-522, 2013

55 Rodrigo GJ, "Efficacy and safety of a fixed-dose combination of indacaterol and Glycopyrronium for the treatment of COPD: a systematic review" 146 : 309-317, 2014

56 Kerwin E, "Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study" 40 : 1106-1114, 2012

57 Anthonisen NR, "Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study" 272 : 1497-1505, 1994

58 Rice KL, "Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction" 81 : 287-292, 1987

59 Calverley PM, "Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease" 176 : 154-161, 2007

60 Jabbour A, "Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial" 55 : 1780-1787, 2010

61 Fabbri LM, "Complex chronic comorbidities of COPD" 31 : 204-212, 2008

62 Almagro P, "Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study" 142 : 1126-1133, 2012

63 Calverley P, "Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial" 361 : 449-456, 2003

64 Karner C, "Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease" 3 : CD008532-, 2011

65 Barnes PJ, "Chronic obstructive pulmonary disease: molecular and cellular mechanisms" 22 : 672-688, 2003

66 Lopez AD, "Chronic obstructive pulmonary disease: current burden and future projections" 27 : 397-412, 2006

67 Salpeter S, "Cardioselective betablockers for chronic obstructive pulmonary disease" 4 : CD003566-, 2005

68 황용일, "COPD 환자에서 우울증 선별검사" 대한내과학회 83 (83): 468-475, 2012

69 Benfield T, "COPD stage and risk of hospitalization for infectious disease" 134 : 46-53, 2008

70 Wedzicha JA, "COPD exacerbations: defining their cause and prevention" 370 : 786-796, 2007

71 Korean Academy of Tuberculosis and Respiratory Diseases, "COPD clinical practice guidelines revised in 2014"

72 Cao C, "Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis" 7 : e43892-, 2012

73 Albert RK, "Azithromycin for prevention of exacerbations of COPD" 365 : 689-698, 2011

74 Kim J, "Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study" 13 : 51-, 2013

75 Anthonisen NR, "Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease" 106 : 196-204, 1987

76 Wedzicha JA, "Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study" 1 : 199-209, 2013

77 Eisner MD, "An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease" 182 : 693-718, 2010

78 Nici L, "American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation" 173 : 1390-1413, 2006

79 Sciurba FC, "A randomized study of endobronchial valves for advanced emphysema" 363 : 1233-1244, 2010

80 Chapman KR, "A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study" 14 : 4-, 2014

81 Tashkin DP, "A 4-year trial of tiotropium in chronic obstructive pulmonary disease" 359 : 1543-1554, 2008

82 Statistics Korea, "2010 Morbidity statistics on causes of death among Koreans" Statistics Korea 2011